Douglas B. Johnson, MD, MSCI | Authors

April 15, 2018

In this article, we detail the experience with immune checkpoint inhibitors in patients with autoimmune disease.

December 15, 2015

In view of the potential for durable responses with immunotherapy, it will be important to identify the most effective and least toxic regimens for individual patients.